We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+19.18%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$14.1B
AUM Growth
+$3.8B
Cap. Flow
+$2.09B
Cap. Flow %
14.81%
Top 10 Hldgs %
19.63%
Holding
2,124
New
675
Increased
443
Reduced
410
Closed
576

Top Buys

Rank Stock Value
1
FIS icon
Fidelity National Information Services
FIS
+$188M
2
AMZN icon
Amazon
AMZN
+$137M
3
ADBE icon
Adobe
ADBE
+$110M
4
EA
Electronic Arts
EA
+$110M
5
PFE icon
Pfizer
PFE
+$109M

Top Sells

Rank Stock Value
1
CMCSA icon
Comcast
CMCSA
+$131M
2
MSFT icon
Microsoft
MSFT
+$129M
3
V icon
Visa
V
+$119M
4
BKNG icon
Booking.com
BKNG
+$86M
5
HUM icon
Humana
HUM
+$82.2M

Sector Composition

Rank Sector Weight
1 Healthcare 31.67%
2 Technology 15.37%
3 Consumer Discretionary 10.44%
4 Industrials 8.59%
5 Financials 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARMK icon
226
Aramark
ARMK
$14.7B
$8.63M 0.06%
404,452
-91,170
-18% -$2.04M
CTRA
227
DELISTED
Coterra Energy
CTRA
$8.6M 0.06%
+329,671
New +$8.27M
BJ icon
228
BJs Wholesale Club
BJ
$12.3B
$8.57M 0.06%
312,924
+301,878
+2,733% +$7.7M
WVE icon
229
Wave Life Sciences
WVE
$1.2B
$8.56M 0.06%
+220,321
New +$8.94M
CCI icon
230
Crown Castle
CCI
$32.2B
$8.55M 0.06%
66,780
+38,381
+135% +$4.5M
HZNP
231
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$8.4M 0.06%
317,854
+202,785
+176% +$4.81M
PARA
232
DELISTED
Paramount Global Class B
PARA
$8.34M 0.06%
175,380
-135,566
-44% -$6.6M
EQR icon
233
Equity Residential
EQR
$25.1B
$8.33M 0.06%
110,628
-7,220
-6% -$520K
NTAP icon
234
NetApp
NTAP
$37.2B
$8.32M 0.06%
119,994
+103,545
+629% +$6.68M
TNDM icon
235
Tandem Diabetes Care
TNDM
$1.56B
$8.31M 0.06%
130,837
+26,873
+26% +$1.41M
ICUI icon
236
ICU Medical
ICUI
$4.61B
$8.3M 0.06%
34,686
-18,987
-35% -$4.55M
PTR
237
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$8.29M 0.06%
126,636
-29,011
-19% -$1.88M
BNFT
238
DELISTED
Benefitfocus, Inc.
BNFT
$8.08M 0.06%
163,165
+162,172
+16,332% +$8.29M
SNAP icon
239
Snap
SNAP
$9.01B
$8.06M 0.06%
+731,246
New +$6.22M
TTWO icon
240
Take-Two Interactive
TTWO
$46.1B
$8.05M 0.06%
85,298
-33,589
-28% -$3.26M
NTR icon
241
Nutrien
NTR
$30.7B
$8.04M 0.06%
152,401
+71,188
+88% +$3.71M
ATR icon
242
AptarGroup
ATR
$8.61B
$7.96M 0.06%
+74,809
New +$7.47M
SUPN icon
243
Supernus Pharmaceuticals
SUPN
$2.77B
$7.93M 0.06%
226,293
+60,880
+37% +$2.27M
AWI icon
244
Armstrong World Industries
AWI
$7.84B
$7.9M 0.06%
99,502
+88,490
+804% +$6.17M
FAF icon
245
First American
FAF
$7.58B
$7.88M 0.06%
152,934
+44,182
+41% +$2.19M
CELG
246
DELISTED
Celgene Corp
CELG
$7.73M 0.05%
81,936
+44,184
+117% +$3.86M
TWTR
247
DELISTED
Twitter, Inc.
TWTR
$7.71M 0.05%
+234,575
New +$7.43M
HAL icon
248
Halliburton
HAL
$26.6B
$7.51M 0.05%
+256,191
New +$7.74M
MASI
249
DELISTED
Masimo
MASI
$7.5M 0.05%
54,209
-14,675
-21% -$1.84M
GDOT icon
250
Green Dot
GDOT
$745M
$7.49M 0.05%
+123,475
New +$8.61M
8 9
10
11 12

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q1 2019 Portfolio in Review

As of Q1 2019, Marshall Wace North America held 2,124 positions worth $14.1B, up 37% from $10.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace North America deployed $2.09B of net new capital in Q1 2019, opening 675 new positions and adding to 443 existing holdings. Its largest new stake was bluebird bio: 36,744 shares worth $74.9M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 29% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Comcast, an estimated $131M trimmed.

  • Marshall Wace North America's largest Q1 2019 buy was bluebird bio: 36,744 shares worth $74.9M.
  • Marshall Wace North America added most to Fidelity National Information Services in Q1 2019, an estimated $188M increase.
  • Marshall Wace North America's biggest Q1 2019 reduction was Comcast, cutting an estimated $131M.
  • Marshall Wace North America fully exited Cboe Global Markets in Q1 2019, selling an estimated $67.7M.
  • Marshall Wace North America's ten largest holdings make up 20% of its $14.1B portfolio in Q1 2019.
  • Marshall Wace North America opened 675 new positions and closed 576 in Q1 2019.
  • Marshall Wace North America's portfolio value rose 37% quarter-over-quarter to $14.1B.

Based on Marshall Wace North America's 13F filing for Q1 2019, filed 14 May 2019.